Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Winter

Showing results (421-430 of 428) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 428 results.
The Lancet. Psychiatry|January 5, 2016
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trialR Hamish McAllister-Williams, Ian M Anderson, Andreas Finkelmeyer, et al.
Berliner Und Munchener Tierarztliche Wochenschrift|August 19, 2011
[Epidemiological enquiries in two Q fever outbreaks in a community of Baden-Württemberg during 2008 and 2009]Angela Hilbert, Peter Reith, Stefan O Brockmann, et al.
ESMO Open|September 6, 2021
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinomaM Kirchner, K Kluck, R Brandt, et al.
BMC Psychiatry|August 7, 2013
Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)R Hamish McAllister-Williams, Eleanor Smith, Ian M Anderson, et al.
Journal of Clinical Pharmacology|July 17, 2001
Immunological and molecular analysis of the sentinel lymph node: a potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine developmentS L Meijer, A Dols, H M Hu, et al.
The Journal of Pathology|February 28, 2015
Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder?Philip M Kluin, Anton W Langerak, Jannetta Beverdam-Vincent, et al.
Journal of Crohn'S & Colitis|June 10, 2014
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's diseaseF M Ruemmele, G Veres, K L Kolho, et al.
ESMO Open|September 4, 2021
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerG Mountzios, E Samantas, K Senghas, et al.
Pageof 43

Showing results (421-430 of 428) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 428 results.
The Lancet. Psychiatry|January 5, 2016
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trialR Hamish McAllister-Williams, Ian M Anderson, Andreas Finkelmeyer, et al.
Berliner Und Munchener Tierarztliche Wochenschrift|August 19, 2011
[Epidemiological enquiries in two Q fever outbreaks in a community of Baden-Württemberg during 2008 and 2009]Angela Hilbert, Peter Reith, Stefan O Brockmann, et al.
ESMO Open|September 6, 2021
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinomaM Kirchner, K Kluck, R Brandt, et al.
BMC Psychiatry|August 7, 2013
Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)R Hamish McAllister-Williams, Eleanor Smith, Ian M Anderson, et al.
Journal of Clinical Pharmacology|July 17, 2001
Immunological and molecular analysis of the sentinel lymph node: a potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine developmentS L Meijer, A Dols, H M Hu, et al.
The Journal of Pathology|February 28, 2015
Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder?Philip M Kluin, Anton W Langerak, Jannetta Beverdam-Vincent, et al.
Journal of Crohn'S & Colitis|June 10, 2014
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's diseaseF M Ruemmele, G Veres, K L Kolho, et al.
ESMO Open|September 4, 2021
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerG Mountzios, E Samantas, K Senghas, et al.
Pageof 43